Daniela Miglietta
Parma, 43122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis.
Journal: Journal of medicinal chemistry
Published: November 27, 2025
STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD.
STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD.
Journal: ERJ open research
Published: September 23, 2025
Differential Expression of Type 1 and Type 17 Immune Pathways and Chemokines in Mild-to-Severe Asthma With Mid to High Neutrophilic Inflammation.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: October 24, 2024
Comparison of Formoterol, Glycopyrrolate, and Beclomethasone Dipropionate Pharmacokinetic Profile after Inhaled Administration as pMDI Using HFA134a or HFA152a Propellant: Preclinical Assessment of Drug Exposure in Sprague-Dawley Rat Model.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: September 26, 2024
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Journal: Journal of medicinal chemistry
Published: June 10, 2024
Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis.
Journal: Frontiers in pharmacology
Published: September 28, 2023
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Journal: Journal of medicinal chemistry
Published: July 28, 2022
Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.
Journal: Pulmonary pharmacology & therapeutics
Published: May 31, 2019
NO donors exhibit anti-inflammatory properties by modulating inflammatory signatures and by regulating the life cycle of dendritic cells.
Journal: Journal of leukocyte biology
Published: September 07, 2016
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
Journal: Orphanet journal of rare diseases
Published: February 24, 2015
Last Updated: 09/26/2026